News
Russia’s COVID-19 vaccine to enter production, deliver first batch...
The world's first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry for...
News
TIACA and Pharma.Aero Join Forces to Prepare Air Cargo...
The International Air Cargo Association (TIACA) and Pharma.Aero have joined forces to develop global guidance for the air cargo industry to enable optimal transportation of...
News
FDA Accepts Biogens Aducanumab Biologics License Application for Alzheimer’s...
Biogen and Eisai, Co., Ltd. announced that the U.S. FDA has accepted the Biologics License Application (BLA) for aducanumab, an investigational treatment for Alzheimer’s disease....
Drug Research
Caprion-HistoGeneX, Viroclinics-DDL Announce COVID-19 Research Partnership
Caprion-HistoGeneX and Viroclinics-DDL announced a new strategic partnership to expand their global capabilities addressing the emerging needs for therapeutic and prophylactic solutions to target infectious...
News
Pfizer and BioNTech Announce Early Positive Data from an...
Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program, Project Lightspeed, against SARS-CoV-2, were published online in...
News
Gilead Submits New Drug Application to U.S. FDA for...
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. FDA for Veklury® (remdesivir), an investigational antiviral for the...
News
Novavax Inc and Serum Institute of India Announce Development...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced a license agreement with Serum Institute of India Private Limited (SIIPL)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.